beta-1,4-galactosyltransferase VII (20-29)

Beta-1,4-galactosyltransferase VII (20-29) is a synthetic peptide fragment derived from the seventh isoform of the beta-1,4-galactosyltransferase (B4GALT7) enzyme, specifically encompassing amino acid residues 20 to 29. As a peptide reagent, it is of significant interest in biochemical research focused on glycosyltransferase structure, substrate specificity, and enzyme-substrate interactions. The B4GALT7 enzyme plays an essential role in the biosynthesis of glycosaminoglycans, contributing to the formation of proteoglycans within the extracellular matrix. By isolating and studying this defined peptide segment, researchers can gain valuable insights into the functional domains of B4GALT7 and its involvement in complex glycosylation pathways.

Enzyme Mechanism Studies: The peptide serves as a useful tool for probing the enzymatic mechanisms of beta-1,4-galactosyltransferase VII. By employing this fragment in in vitro assays, researchers can investigate the specific amino acid contributions to catalytic activity, substrate recognition, or cofactor binding. Such studies help elucidate how particular sequence motifs within B4GALT7 influence its glycosyltransferase function, ultimately advancing the broader understanding of glycan biosynthesis.

Antibody Production and Epitope Mapping: The defined sequence of residues 20-29 enables its use as an immunogen for generating sequence-specific antibodies against B4GALT7. These antibodies can be applied in immunodetection protocols, such as Western blotting or immunoprecipitation, to study the expression, localization, and regulation of the native enzyme. Additionally, the peptide is valuable in epitope mapping experiments, helping to define antibody binding sites and validate antibody specificity for research and diagnostic applications.

Protein-Protein Interaction Analysis: As a representative segment of the B4GALT7 enzyme, this peptide can be employed in protein interaction studies to identify binding partners or modulators that associate with this region. Techniques such as peptide pull-down assays, surface plasmon resonance, or affinity chromatography can utilize the fragment to uncover molecular interactions that regulate the function or stability of B4GALT7 within cellular contexts.

Structural and Conformational Research: The isolated peptide offers a simplified model for investigating the local secondary structure and conformational dynamics of the B4GALT7 enzyme. Through spectroscopic techniques like circular dichroism or nuclear magnetic resonance, researchers can characterize the folding properties and flexibility of this segment, thereby informing computational models or guiding mutagenesis studies aimed at dissecting structure-function relationships.

Peptide-Based Assay Development: The sequence-specific nature of this fragment allows it to be incorporated into custom assay formats designed to monitor enzymatic activity or screen for potential inhibitors of B4GALT7. By serving as a substrate mimic or competitive ligand, the peptide facilitates the development of high-throughput screening assays or biochemical tests that support drug discovery and functional genomics research targeting glycosylation pathways.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides